Tetra Pharm Technologies announces successful In-Vitro drug release test of new analgesic compound
The Danish biotech company, Tetra Pharm Technologies, announces promising results from preclinical testing of its pain-relieving drug -…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Jun 23
The Danish biotech company, Tetra Pharm Technologies, announces promising results from preclinical testing of its pain-relieving drug -…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
14 Jun 23
Company expanding from AI-powered Data Verification Tool to ‘complete submission’ data platform
14 Jun 23
Venlo, the Netherlands, and Redwood City, California, June13, 2023 (GLOBE NEWSWIRE) -- QIAGEN (NYSE: QGEN; Frankfurt Prime Standard:…
13 Jun 23
The company will expand its existing Active Pharmaceutical Ingredient (API) production facility in Denmark for the future portfolio…
13 Jun 23
The FDA approval is based on the findings from a Phase 3 trial which showed a statistically significant…
13 Jun 23
The approval will enable the Swiss company to scale up its drug substance manufacturing process for ADSTILADRIN at…
13 Jun 23
Under the partnership, Curigin will use Charles River's expertise in contract development and manufacturing organisation solutions for supporting…
13 Jun 23
Signals Research Suite integrates workflows across biology, chemistry and materials new product development to arm scientists with better…
13 Jun 23
Product eliminates the need for two discrete syringe preparations and administrations, which helps increase efficiency for hospitals and…
12 Jun 23
The deal will give Novartis two late-stage medicines for the treatment of IgA nephropathy in the form of…